@prefix this: . @prefix rdfs: . @prefix xsd: . @prefix sio: . @prefix ncit: . @prefix lld: . @prefix miriam-gene: . @prefix miriam-pubmed: . @prefix eco: . @prefix wi: . @prefix prov: . @prefix pav: . @prefix prv: . @prefix dcterms: . @prefix np: . @prefix dgn-np: . @prefix dgn-gda: . @prefix dgn-void: . dgn-np:NP868916.RAjBKF8cKvDXgP885QT0mEnlcXKPHnQPFBNXyDoDtvY0M130_head { this: np:hasAssertion dgn-np:NP868916.RAjBKF8cKvDXgP885QT0mEnlcXKPHnQPFBNXyDoDtvY0M130_assertion; np:hasProvenance dgn-np:NP868916.RAjBKF8cKvDXgP885QT0mEnlcXKPHnQPFBNXyDoDtvY0M130_provenance; np:hasPublicationInfo dgn-np:NP868916.RAjBKF8cKvDXgP885QT0mEnlcXKPHnQPFBNXyDoDtvY0M130_publicationInfo; a np:Nanopublication . dgn-np:NP868916.RAjBKF8cKvDXgP885QT0mEnlcXKPHnQPFBNXyDoDtvY0M130_assertion a np:Assertion . dgn-np:NP868916.RAjBKF8cKvDXgP885QT0mEnlcXKPHnQPFBNXyDoDtvY0M130_provenance a np:Provenance . dgn-np:NP868916.RAjBKF8cKvDXgP885QT0mEnlcXKPHnQPFBNXyDoDtvY0M130_publicationInfo a np:PublicationInfo . } dgn-np:NP868916.RAjBKF8cKvDXgP885QT0mEnlcXKPHnQPFBNXyDoDtvY0M130_assertion { miriam-gene:23158 a ncit:C16612 . lld:C0023487 a ncit:C7057 . dgn-gda:DGN44e6670bf3c3837a5f7d57422bc9ddef sio:SIO_000628 miriam-gene:23158, lld:C0023487; a sio:SIO_001123 . } dgn-np:NP868916.RAjBKF8cKvDXgP885QT0mEnlcXKPHnQPFBNXyDoDtvY0M130_provenance { dgn-np:NP868916.RAjBKF8cKvDXgP885QT0mEnlcXKPHnQPFBNXyDoDtvY0M130_assertion dcterms:description "[By liquid culture of leukemia cell lines and fresh AML cells with the addition of all-trans retinoic acid (ATRA), modulation of P-gp/MDR1 and Egr1 was observed and the pattern of modulation was divided into four groups: (1) blastic AML type, in which distinct expression of P-gp/MDR1 and CD34 was not influenced by ATRA; (2) t(8;21)AML type, in which P-gp/MDR1 expression was augmented by ATRA, while CD34 was kept high; (3) AML M3 type, in which P-gp/MDR1 expression was reduced with granulocytic differentiation by ATRA; (4) monocytic AML type, in which P-gp/MDR1 expression was augmented by ATRA, while CD34 expression decreased, and strong Egr1 expression was downregulated just prior to the augmentation of P-gp/MDR1 expression.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en; wi:evidence dgn-void:source_evidence_literature; sio:SIO_000772 miriam-pubmed:11734301; prov:wasDerivedFrom dgn-void:befree-20150227; prov:wasGeneratedBy eco:ECO_0000203 . dgn-void:befree-20150227 pav:importedOn "2015-02-27"^^xsd:date . dgn-void:source_evidence_literature a eco:ECO_0000212; rdfs:comment "Gene-disease associations inferred from text-mining the literature."@en; rdfs:label "DisGeNET evidence - LITERATURE"@en . } dgn-np:NP868916.RAjBKF8cKvDXgP885QT0mEnlcXKPHnQPFBNXyDoDtvY0M130_publicationInfo { this: dcterms:created "2015-08-25T14:46:28+02:00"^^xsd:dateTime; dcterms:rights ; dcterms:rightsHolder dgn-void:IBIGroup; dcterms:subject sio:SIO_000983; prv:usedData dgn-void:disgenetv3.0rdf; pav:authoredBy , , , , ; pav:createdBy ; pav:version "v3.0.0.0" . dgn-void:disgenetv3.0rdf pav:version "v3.0.0" . }